On Wednesday, AmerisourceBergen Corp. (NYSE: ABC), Conshohocken, Pennsylvania, reported sales for fiscal third quarter of $53.billion, an increase of 18% year-over-year.
The increase was largely driven by a 13.2% surge in the company’s Pharmaceutical Distribution Services revenue. The company reported third-quarter net income of $292 million. Gross profit in the third quarter of fiscal 2021 was $1.9 billion, a 54% increase compared to the same period in the previous fiscal year.
“During the third quarter, AmerisourceBergen continued to capitalize on our differentiated, pharmaceutical-centric value proposition and successfully executed on our key strategic initiatives including completing the acquisition of Alliance Healthcare,” said Steven H. Collis, Chairman, President and Chief Executive Officer of AmerisourceBergen. “We are proud of the execution by our teams to deliver these results and pleased to increase financial guidance for fiscal 2021 to reflect the continued strong performance across our businesses.”
Going forward, AmerisourceBergen anticipates full-year earnings to be in the range of $9.15 to $9.30 per share.